Company Filing History:
Years Active: 2020
Title: Xikui Liu: Innovator in Cellular Therapy
Introduction
Xikui Liu is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical therapy, particularly in adoptive cellular therapies. His innovative work focuses on enhancing therapeutic effects through the use of specific agonists.
Latest Patents
Xikui Liu holds 1 patent for his invention titled "Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods." This invention relates to medical therapy that utilizes an agonist of the retinoic acid receptor-related orphan receptor gamma (RORγ). It provides methods for enhancing the therapeutic effects of lymphocyte cells and dendritic cells in patients by administering an agonist of RORγ.
Career Highlights
Xikui Liu is currently associated with Lycera Corporation, where he continues to advance his research and development in cellular therapies. His work has the potential to significantly impact the treatment of various medical conditions through innovative therapeutic methods.
Collaborations
Some of his notable coworkers include Gary D. Glick and Peter Laurence Toogood. Their collaboration contributes to the advancement of research in the field of cellular therapy.
Conclusion
Xikui Liu's contributions to adoptive cellular therapy represent a significant advancement in medical treatment options. His innovative approach using RORγ agonists showcases the potential for improved therapeutic outcomes in patients.